Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fetal bone cells for tissue engineering.

Marc-Olivier Montjovent1, Nathalie Burri, Silke Mark

  • 1Bone Bioengineering Group, Orthopedic Research Center, Swiss Federal Institute of Technology Lausanne, Switzerland.

Bone
|December 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>N</i>-Methylation of Legionaminic Acid in <i>Legionella pneumophila</i> Serogroup 1 LPS Affects Cell Surface Properties, Intracellular Growth, and Cytokine Response.

Pathogens (Basel, Switzerland)·2026
Same author

Wastewater-Based Assessment of Antimicrobial Resistance and Bacterial Communities in Urban and Rural Areas in the Province of Trento (Italy).

MicrobiologyOpen·2026
Same author

Adhesive hydrogel-enabled integrative fixation for cartilage and osteochondral repair.

Frontiers in bioengineering and biotechnology·2026
Same author

In Vitro Evaluation of an Adhesive Hydrogel-Based Chondrocyte Carrier for Enhanced Therapeutic Delivery.

Macromolecular bioscience·2026
Same author

Patient-reported outcome using EFAS score in skeletally mature clubfoot patients treated at birth with Ponseti's technique.

Journal of children's orthopaedics·2026
Same author

Unravelling the Genomic and Virulence Diversity of <i>Legionella pneumophila</i> Strains Isolated from Anthropogenic Water Systems.

Microorganisms·2025
Same journal

Disrupted phosphate metabolism and SIBLING/ASARM peptide accumulation underlie impaired bone mineralization in klotho-deficient (kl/kl) mice.

Bone·2026
Same journal

Linking genetic variants to bone microstructure: Histological signatures of osteogenesis imperfecta subtypes.

Bone·2026
Same journal

The impact of alcohol consumption on bone mineral density: Insights from cross-sectional and Mendelian randomization studies.

Bone·2026
Same journal

Systemic and local predictors of medication-related osteonecrosis of the jaw in patients receiving antiresorptive therapy: The Shizuoka Kokuho Database study.

Bone·2026
Same journal

Long-term exposure to ambient air pollution and risk of non-traumatic osteonecrosis of the femoral head: A nationwide cohort study.

Bone·2026
Same journal

Burden of disease in US patients with skeletal versus muscular or pain manifestations of hypophosphatasia: An analysis from the Global HPP Registry.

Bone·2026
See all related articles

Human fetal bone cells offer promising potential for bone tissue engineering due to their rapid growth and osteogenic differentiation capabilities, outperforming adult bone cells in vitro. This research highlights their value for skeletal regeneration therapies.

Area of Science:

  • Cell Biology
  • Biomaterials Science
  • Regenerative Medicine

Background:

  • Human fetal bone cells are proposed for engineered regeneration of adult skeletal tissue.
  • Characterization of fetal bone cells is crucial as osteoblast protein secretion changes with age.
  • Limited data exists on human fetal bone cells treated with differentiation factors.

Purpose of the Study:

  • To compare the proliferation and osteogenic differentiation potential of human fetal bone cells versus adult bone cells and mesenchymal stem cells in vitro.
  • To detail the behavior of fetal bone cells when exposed to osteogenic factors.

Main Methods:

  • Comparative analysis of cell proliferation, gene expression (bone markers), alkaline phosphatase (ALP) activity, and mineralization over time.
  • Treatment of fetal bone cells with osteogenic factors, including dexamethasone and 1alpha,25-dihydroxyvitamin D3.

Related Experiment Videos

  • Assessment of calcium deposits, nodule formation, and calcification in the extracellular matrix.

    • Main Results:

    • Fetal bone cells exhibited a shorter doubling time than adult bone cells, comparable to mesenchymal stem cells.
    • Upregulation of bone markers (cbfa-1, ALP, collagen I, osteocalcin) was higher in fetal bone cells.
    • Fetal bone cells showed earlier mineralization and increased nodule formation/calcification with differentiation factors, particularly dexamethasone.

    Conclusions:

    • Human primary fetal bone cells demonstrate rapid growth and robust osteogenic differentiation potential.
    • These cells are of significant interest for bone research and hold promise for therapeutic applications in bone tissue engineering.